Redhill Biopharma Ltd
Change company Symbol lookup
Select an option...
RDHL Redhill Biopharma Ltd
CNCE Concert Pharmaceuticals Inc
BL Blackline Inc
DFEN Direxion Daily Aerospace & Defense Bull 3X Shares Direxion Daily Aerospace
NVRO Nevro Corp
DBI Designer Brands Inc
UONE Urban One Inc
SONY Sony Group Corp
PBF PBF Energy Inc
TRP TC Energy Corp
Go

Health Care : Pharmaceuticals |
Based in Israel
Company profile

Redhill Biopharma Ltd is an Israel-basedis a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The Company promotes three gastrointestinal drugs in the US: Movantik, Talicia and Aemcolo. Key programs in it pipeline of late-stage clinical assets include: opaganib (Yeliva) and RHB-107 for multiple indications including COVID-19, RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease and RHB-104 for Crohn's disease.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$2.39
Day's Change
-0.01 (-0.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.47
Day's Low
2.32
Volume
(Light)
Volume:
268,394

10-day average volume:
596,985
268,394
  • Prev Close
    2.40
  • Today's Open
    2.40
  • Day's Range
    2.32-2.47
  • Avg Vol (10-day)
    597.0K
  • Last (time)
    4:00p ET 01/25/22
  • Last (size)
    4
  • 52-Wk Range
    2.24 - 11.52
    LowHigh
  • (02/22/21 - 12/29/21)
    6.70%
  • 87.5%
  • Market Cap
    125.2M
  • Shares Outstanding
    52.4M
  • -2.26
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.7
  • 12.15
  • (% of float 12/31/21)
    5.02

Latest News

January 14, 2022
8:35 am ET
PR Newswire
January 13, 2022
10:35 am ET
PR Newswire
January 06, 2022
9:15 am ET
PR Newswire
December 20, 2021
8:35 am ET
PR Newswire
December 15, 2021
9:16 am ET
Accesswire
9:15 am ET
PR Newswire
December 09, 2021
12:19 pm ET
PR Newswire
9:32 am ET
PR Newswire
7:16 am ET
Accesswire
December 07, 2021
8:45 am ET
PR Newswire
December 06, 2021
7:01 am ET
Accesswire
7:00 am ET
PR Newswire
December 02, 2021
7:01 am ET
Accesswire
7:00 am ET
PR Newswire
December 01, 2021
7:22 am ET
PR Newswire
7:03 am ET
Accesswire
November 30, 2021
9:31 am ET
PR Newswire
7:02 am ET
Accesswire
November 24, 2021
7:00 am ET
PR Newswire
November 23, 2021
11:10 am ET
PR Newswire
November 19, 2021
9:09 am ET
PR Newswire
November 18, 2021
4:04 pm ET
PR Newswire
November 15, 2021
7:04 am ET
Accesswire
7:00 am ET
PR Newswire
November 09, 2021
7:00 am ET
PR Newswire
November 08, 2021
7:15 am ET
Accesswire
7:00 am ET
PR Newswire
October 05, 2021
6:59 am ET
MarketWatch
October 04, 2021
8:48 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.